Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose

Researchers have found that popular GLP-1 weight-loss drugs, such as semaglutide, may have additional benefits beyond diabetes and weight management, including reducing the risk of addiction. A study of over 600,000 US veterans revealed that individuals taking these medications were less likely to develop substance use disorders involving various drugs. Those already struggling with addiction experienced fewer overdoses, hospitalizations, and emergency visits while taking GLP-1 drugs. The findings suggest that GLP-1 medications may have a protective effect against addiction and related health issues.

✦ AI-generated summary